All In MedTech

Device Trial Radar · NCT06368622

Evolve China PMCF Study

A Post-Market Clinical Follow-up Study to Evaluate the Long-Term Safety and Effectiveness of Surpass Evolve Flow Diverter System

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

500

Planned (sponsor's estimate)

Start

Apr 24, 2024

Primary completion

Nov 2027

Study completion Aug 2031

Sponsor

Lead sponsor
Stryker NeurovascularPublic (SYK)
Sponsor type
Industry
Collaborators
Stryker (Beijing) Healthcare Products Co., Ltd
First posted
Apr 16, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A prospective, multi-center, single-arm, open-label, observational, post-market clinical follow-up. The expected duration of the study is 8 years (including up to 5-years' follow-up). Each subject will be followed up per standard of care (SoC) at each study site.

Conditions

  • Intracranial Aneurysm

Interventions

  • Surpass Evolve Flow Diverter SystemDevice

    Endovascular treatment with Surpass Evolve Flow Diverter System was performed in patients diagnosed with intracranial aneurysms

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Neurological death or disabling strokeTime frame: 12 months (-3/ +6 months) post-procedure
  2. 100% occlusion without significant parent artery stenosisTime frame: 12 months (-3/+6 months) post-procedure

Locations

24 sites in 1 country. Site status is shown where the registry gives one.

  • Xuanwu Hospital Capital Medical University

    Beijing, China

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, China

  • Peking University Third Hospital

    Beijing, China

21 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.